Nanofluids
hold significant promise in diverse applications,
particularly
in biomedicine, where noble trimetallic nanofluids outperformed their
monometallic counterparts. The composition, morphology, and size of
these nanofluids play pivotal roles in their functionality. Controlled
synthesis methods have garnered attention, focusing on precise morphology,
content, biocompatibility, and versatile chemistry. Understanding
how reaction parameters such as time, reducing agents, stabilizers,
precursor concentration, temperature, and pH affect size and shape
during synthesis is crucial. Trimetallic nanofluids, with their ideal
composition, size, surface structure, and synergistic properties,
are gaining traction in antimicrobial applications. These nanofluids
were tested against seven microorganisms, demonstrating a heightened
antimicrobial efficacy. Computational analyses, including molecular
docking, dynamics, density functional theory (DFT), molecular electrostatic
potential (MESP) analysis, and absorption, distribution, metabolism,
elimination, and toxicology studies (ADMET) provided insights into
binding interactions, energy, reactivity, and safety profiles, affirming
the antimicrobial potential of trimetallic nanofluids. These findings
emphasize the importance of controlled synthesis and computational
validation in harnessing the unique properties of trimetallic nanofluids
for biomedical applications.